Related Experiment Video
Updated: Sep 25, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Determinants of low HDL levels in familial combined hyperlipidemia
Aino Soro1, Matti Jauhiainen, Christian Ehnholm
1Department of Medicine, University of Helsinki, Finland.
Insights
Familial combined hyperlipidemia (FCHL) is linked to lower HDL cholesterol. Higher hepatic lipase (HL) activity and triglyceride enrichment of HDL particles contribute to reduced HDL2 cholesterol levels in affected individuals.
Area of Science:
- Lipid metabolism
- Cardiovascular genetics
Background:
- Familial combined hyperlipidemia (FCHL) is characterized by elevated total cholesterol and/or triglycerides (TGs) and reduced HDL cholesterol.
- Understanding the determinants of HDL cholesterol in FCHL is crucial for managing cardiovascular risk.
Purpose of the Study:
- To investigate the role of key enzymes in regulating HDL cholesterol levels in FCHL.
- To identify specific factors contributing to reduced HDL cholesterol in affected family members.
Main Methods:
- Measured postheparin plasma activities of hepatic lipase (HL), lipoprotein lipase, cholesterol ester transfer protein, and phospholipid transfer protein (PLTP).
- Analyzed lipid and apolipoprotein levels in 228 subjects from 49 FCHL families (affected, unaffected, and spouses).
- Utilized univariate correlation and multivariate regression analyses.
Main Results:
- Affected family members showed significantly lower levels of HDL cholesterol, HDL2 cholesterol, HDL3 cholesterol, and apolipoprotein A-I compared to unaffected relatives and spouses.
- A marked reduction (25.4%) in HDL2 cholesterol was observed in affected individuals.
- Affected individuals exhibited higher hepatic lipase (HL) activity and phospholipid transfer protein (PLTP) activity.
- HL activity was strongly negatively correlated with HDL2 cholesterol levels.
Conclusions:
- Elevated hepatic lipase (HL) activity and triglyceride enrichment of HDL particles are key factors contributing to reduced HDL cholesterol and HDL2 cholesterol in FCHL.
- Gender, HL activity, TG levels, and body mass index independently influence HDL2 cholesterol levels.
Abstract:
In familial combined hyperlipidemia (FCHL), affected family members frequently have reduced levels of HDL cholesterol, in addition to elevated levels of total cholesterol and/or triglycerides (TGs). In the present study, we focused on those determinants that are important regulators of HDL cholesterol levels in FCHL, and measured postheparin plasma activities of hepatic lipase (HL), lipoprotein lipase, cholesterol ester transfer protein, and phospholipid transfer protein (PLTP) in 228 subjects from 49 FCHL families. In affected family members (n = 88), the levels of HDL cholesterol, HDL2 cholesterol, HDL3 cholesterol, and apolipoprotein A-I were lower than in unaffected family members (n = 88) or spouses (n = 52). The main change was the reduction of HDL2 cholesterol by 25.4% in affected family members (P < 0.001 vs. unaffected family members; P = 0.003 vs. spouses). Affected family members had higher HL activity than unaffected family members (P = 0.001) or spouses (P = 0.013). PLTP activity was higher in affected than unaffected family members (P = 0.025). In univariate correlation analysis, a strong negative correlation was observed between HL activity and HDL2 cholesterol (r = -0.339, P < 0.001). Multivariate regression analysis demonstrated that gender, HL activity, TG, and body mass index have independent contributions to HDL2 cholesterol levels. We suggest that in FCHL, TG enrichment of HDL particles and enhanced HL activity lead to the reduction of HDL cholesterol and HDL2 cholesterol.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Pharmacogenomics: Identification of New Drug Targets
Coronary Artery Disease I: Introduction
